U.S. Rep. Rosa DeLauro says the Food and Drug Administration is favoring corporate interests over those of patients in new changes to its process for approving medical devices according to a column this week in the Connecticut Health I-Team report. DeLauro, who has a hip implant, is ranking member of the subcommittee with jurisdiction...










